Effects of drugs with muscle-related side effects and affinity for calsequestrin on the calcium regulatory function of sarcoplasmic reticulum microsomes

Molecular Pharmacology

Volumn 68, Issue 6, 2005, Pages 1708-1715

  Kim, EunJung ^a   Tam, Maggie ^a   Siems, William F ^a   Kang, ChulHee ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTHRACYCLINE DERIVATIVE; CALCIUM; CALSEQUESTRIN; CHLORPROMAZINE; DAUNORUBICIN; DIMETHYL SULFOXIDE; DOPAMINE; DOXORUBICIN; EPHEDRINE; FLUNARIZINE; IMIPRAMINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PHENOTHIAZINE DERIVATIVE; PROMETHAZINE; TETRACYCLINE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; TRYPTOPHAN;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; DRUG BINDING; DRUG EFFICACY; DRUG PENETRATION; HEART MUSCLE; LIQUID CHROMATOGRAPHY; MICROSOME; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SOLUBILITY; TANDEM MASS SPECTROMETRY;

ANIMALS; CALCIUM; CALSEQUESTRIN; MICROSOMES; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOCARDIUM; PHARMACEUTICAL PREPARATIONS; RABBITS; SARCOPLASMIC RETICULUM;

EID: 27844611232     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.016253     Document Type: Article

References (31)

1. Beard N, Laver D, and Dulhunty A (2004) Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 85:33-69.
2. Branden C (1980) Relation between structure and function of a/b proteins. Q Rev Biophys 13:317-338.
3. Buckley N and Sanders P (2000) Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 23:215-228.
4. Charlier JH, Olson R, Thornock C, Mercer W, Olson D, Broyles T, Muhlestein D, Larson C, Cusack B, and Shadle S (2005) investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol and trifluoperazine. Mol Pharmacol 67:1505-1512.
5. Kr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J Pharmacol Exp Ther 313:888-895.
6. Corbett E, Michalak KM, Oikawa K, Johnson S, Campbell ID, Eggleton P, Kay C, and Michalak M (2000) The conformation of calreticulin is influenced by the endoplasmic reticulum luminal environment. J Biol Chem 275:27177-27185.
7. Dachtler M, Handel H, Glaser T, Lindquist D, Hawk RM, Karson CN, Komorsk RA, and Albert K (2000) Identification of trifluoperazine using HPLC-NMR of test mixtures. Magn Reson Chem 38:951-956.
8. Ferrari D and Soling H (1999) The protein disulphide-isomerase family: unravelling a string of folds. Biochem J 339:1-10.
9. Gyorke I, Hester N, Jones L, and Gyorke S (2004) The role of calsequestrin, triadin and junction in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 86:2121-2128.
10. 2+-induced folding and aggregation of skeletal muscle sarcoplasmic reticulum calsequestrin. The involvement of the trifluoperazine-binding site. J Biol Chem 268:24635-24641.
11. Jusic N and Lader M (1994) Post-mortem antipsychotic drug concentrations and unexplained deaths. Br J Psychiatry 165:787-791.
12. Katti S, LeMaster D, and Eklund H (1990) Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. J Mol Biol 212:167-184.
13. 2+ cycling proteins. J Mol Cell Cardiol 34:897-918.
14. MacLennan D and Wong P (1971) Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci USA 68:1231-1235.
15. 2+ binding chaperone of the endoplasmic reticulum. Biochem Cell Biol 76:779-785.
16. 2+-binding proteins and members of the thioredoxin superfamily. J Biol Chem 269:1744-1749.
17. Olson R, Li X, Palade P, Shadle S, Mushlin P, Gambliel H, Fill M, Boucek RJ, and Cusack BJ (2000) Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol. Toxicol Appl Pharmacol 169:168-176.
18. Olson R, Mushlin P, Brenner D, Fleischer S, Cusack B, Chang B, and Boucek RJ (1988) Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci USA 85:3585-3589.
19. Park H, Park I-Y, Kim E, Youn B, Fields K, Dunker A, and Kang C (2004) Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization. J Biol Chem 279:18026-18033.
20. 2+ regulation. J Biol Chem 278:16176-16182.
21. Park I, Kim E, Park H, Fields K, Dunker K, and Kang C (2005) Interaction between cardiac calsequestrin and drugs with known cardiotoxicity: a potential source for the cardiac side effects. Mol Pharmacol 67:97-104.
22. Raehl C, Patel A, and LeRoy M (1985) Drug-induced torsade de pointes. Clin Pharm 4:675-690.
23. Reilly J, Ayis S, Ferrier I, Jones S, and Thomas S (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052.
24. Saito A, Seiler S, Chu A, and Fleischer S (1984) Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 99:875-885.
25. 2+ buffer inside the sarcoplasmic reticulum. Biochem J 337:19-22.
26. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Volpe P, Williams S, and Gyorke S (2003) Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 100:11759-11764.
27. Walter A and Gutknecht J (1986) Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90:207-217.
28. Wang S, Trumble W, Liao H, Wesson C, Dunker A, and Kang C (1998) Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 5:476-483.
29. Witchel H, Hancox J, and Nutt D (2003) Psychotropic drugs, cardiac arrhythmia and sudden death. J Clin Psychopharmacol 23:58-77.
30. Wykovsky W, Hauptner R, and Suko J (1988) Drug-induced calcium release from heavy sarcoplasmic reticulum of skeletal muscle. Biochim Biophys Acta 938:89-96.
31. Zucchi R and Danesi R (2003) Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3:151-171.